Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03201393 · ClinicalTrials.gov registry record · Phase 2
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
A Phase 2 study of Chronic Low Back Pain and Lumbar Radiculopathy, sponsored by Allodynic Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03201393 is a Phase 2 study of Chronic Low Back Pain and Lumbar Radiculopathy that has completed, run by Allodynic Therapeutics. The registered enrollment target is 12 participants, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03201393, a Phase 2 study of Chronic Low Back Pain and Lumbar Radiculopathy, has completed, sponsored by Allodynic Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Treatment of chronic low-back pain with low-dose naltrexone and acetaminophen combination: a small, randomized, double-Blind, and placebo-controlled clinical trial with an open-label extension for none-responders
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Low-dose naltrexone and acetaminophen combination
Study Locations (1)
Florida
- Annette C. Toledano, M.D. - North Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2018-07-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03201393
The ClinicalTrials.gov registry entry for NCT03201393 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (98% lower). The listed sponsor is Allodynic Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03201393 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03201393 about?
NCT03201393 is a clinical study titled "Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)". Treatment of chronic low-back pain with low-dose naltrexone and acetaminophen combination: a small, randomized, double-Blind, and placebo-controlled clinical trial with an open-label extension for none-responders
What is the current status of trial NCT03201393?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2017-08-15. Estimated completion is 2018-07-26.
What conditions does trial NCT03201393 study?
This clinical trial studies the following conditions: Chronic Low Back Pain, Lumbar Radiculopathy.
What interventions are being tested in trial NCT03201393?
The interventions under investigation include: Placebo (DRUG), Low-dose naltrexone and acetaminophen combination (DRUG).
Who is sponsoring clinical trial NCT03201393?
This trial is sponsored by Allodynic Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03201393 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
RECRUITING · Phase 2
-
Modulation Effect of tACS on Chronic Low Back Pain
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Chronic Low Back Pain Research Project
COMPLETED · Phase 2
-
Treating Negative Affect in Low Back Pain Patients
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.